Impact of single nucleotide polymorphism in IL-4, IL-4R genes and systemic concentration of IL-4 on the incidence of glioma in Iraqi patients

International Journal of Medical Sciences

Volumn 11, Issue 11, 2014, Pages 1147-1153

  Shamran, Haidar A ^a,e   Hamza, Subah J ^a   Yaseen, Nahi Y ^b   Al Juboory, Ahmad A ^c   Taub, Dennis D ^d   Price, Robert L ^e   Nagarkatti, Mitzi ^e   Nagarkatti, Prakash S ^e   Singh, Udai P ^e  

^a AL NAHRAIN UNIVERSITY   (Iraq)

^b MUSTANSIRIYAH UNIVERSITY   (Iraq)

^c UNIVERSITY OF BAGHDAD   (Iraq)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

And glioma; Brain tumor; Interleukin 4; Interleukin 4R; Single nucleotide polymorphism (SNPs)

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CHILD; CONTROLLED STUDY; DNA SEQUENCE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLIOMA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IL 4 GENE; IL 4R GENE; IRAQI; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; IRAQ; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HUMANS; INCIDENCE; INTERLEUKIN-4; IRAQ; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-4; YOUNG ADULT;

EID: 84906737233     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.9412     Document Type: Article

References (42)

1. Kyritsis AP, Bondy ML, Rao JS, Sioka C: Inherited predisposition to glioma. Neuro-Oncology 2010, 12(1): 104-113.
2. Prasad G, Haas-Kogan DA: Radiation-induced gliomas. Expert Review of Neurotherapeutics 2009, 9(10): 1511-1517.
3. Ohgaki H, Kleihues P: Epidemiology and etiology of gliomas. Acta Neuropathologica 2005, 109(1): 93-108.
4. Davis F, Il'yasova D, Rankin K, McCarthy B, Bigner DD: Medical diagnostic radiation exposures and risk of gliomas. Radiation Research 2011, 175(6): 790-796.
5. Melin B: Genetic causes of glioma: new leads in the labyrinth. Curr Opin Oncol 2011, 23(6): 643-647.
6. Lohr J, Ratliff T, Huppertz A, Ge Y, Dictus C, Ahmadi R, Grau S, Hiraoka N, Eckstein V, Ecker RC et al: Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-beta. Clin Cancer Res 2011, 17(13): 4296-4308.
7. Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N, Gohlke H, Wagenpfeil S, Ollert M, Ring J et al: Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 2008, 4(8): e1000166.
8. Mearns H, Horsnell WG, Hoving JC, Dewals B, Cutler AJ, Kirstein F, Myburgh E, Arendse B, Brombacher F: Interleukin-4-promoted T helper 2 responses enhance Nippostrongylus brasiliensis-induced pulmonary pathology. Infection & Immunity 2008, 76(12): 5535-5542.
9. Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS: Frequency of interleukin-4 (IL-4)-589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis 2005, 40(9): 1258-1262.
10. Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD: Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 2007, 28(12): 2543-2547.
11. Jin T, Li X, Zhang J, Wang H, Geng T, Li G, Gao G, Chen C: Genetic association between selected cytokine genes and glioblastoma in the Han Chinese population. BMC Cancer 2013, 13: 236.
12. Wang XW, Boisselier B, Rossetto M, Marie Y, Idbaih A, Mokhtari K, Gousias K, Hoang-Xuan K, Delattre JY, Simon M et al: Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas. Cancer 2013, 119(4): 806-813.
13. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC: Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev 2007, 31(5): 345-351.
14. Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, Kumar R, Forsti A, Kjellberg L, Hallmans G et al: Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int J Cancer 2009, 125(8): 1851-1858.
15. Mohan S, Mohanasenthil, Paul SF, Shroff S, Venkatesan V: Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prev 2009, 10(2): 295-298.
16. Chu H, Wang M, Yan F, Zhong D, Shi D, Ma L, Pan X, Qin C, Yin C, Zhang Z: Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Ann Oncol 2012, 23(8): 2114-2121.
17. Ford AQ, Heller NM, Stephenson L, Boothby MR, Keegan AD: An atopy-associated polymorphism in the ectodomain of the IL-4R(alpha) chain (V50) regulates the persistence of STAT6 phosphorylation. J Immunol 2009, 183(3): 1607-1616.
18. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM et al: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998, 282(5397): 2261-2263.
19. Scheurer ME, Amirian E, Cao Y, Gilbert MR, Aldape KD, Kornguth DG, El-Zein R, Bondy ML: Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clinical Cancer Research 2008, 14(20): 6640-6646.
20. Kabesch M, Tzotcheva I, Carr D, Hofler C, Weiland SK, Fritzsch C, von Mutius E, Martinez FD: A complete screening of the IL-4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003, 112(5): 893-898.
21. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L: Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clinical & Experimental Allergy 1995, 25 Suppl 2: 74-78; discussion 95-76.
22. Bush A, Pedersen S, Hedlin G, Baraldi E, Barbato A, de Benedictis F, Lodrup Carlsen KC, de Jongste J, Piacentini G: Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? Eur Respir J 2011, 38(4): 947-958.
23. Busse WW: Asthma diagnosis and treatment: filling in the information gaps. J Allergy Clin Immunol 2011, 128(4): 740-750.
24. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J et al: Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004, 364(9444): 1505-1512.
25. Almomani B, Hawwa AF, Millership JS, Heaney L, Douglas I, McElnay JC, Shields MD: Can certain genotypes predispose to poor asthma control in children? A pharmacogenetic study of 9 candidate genes in children with difficult asthma. PLoS One 2013, 8(4): e60592.
26. Carmody SR, Wente SR: mRNA nuclear export at a glance. J Cell Sci 2009, 122(Pt 12): 1933-1937.
27. Gervaziev YV, Kaznacheev VA, Gervazieva VB: Allelic polymorphisms in the interleukin-4 promoter regions and their association with bronchial asthma among the Russian population. Int Arch Allergy Immunol 2006, 141(3): 257-264.
28. Callard RE, Matthews DJ, Hibbert L: IL-4 and IL-13 receptors: are they one and the same? Immunol Today 1996, 17(3): 108-110.
29. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996, 183(1): 109-117.
30. Kruse S, Japha T, Tedner M, Sparholt SH, Forster J, Kuehr J, Deichmann KA: The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999, 96(3): 365-371.
31. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE: An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994, 76(5): 811-820.
32. Stephenson L, Johns MH, Woodward E, Mora AL, Boothby M: An IL-4R alpha allelic variant, I50, acts as a gain-of-function variant relative to V50 for Stat6, but not Th2 differentiation. Journal of Immunology 2004, 173(7): 4523-4528.
33. Barna BP, Estes ML, Pettay J, Iwasaki K, Zhou P, Barnett GH: Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression. J Neuroimmunol 1995, 60(1-2): 75-81.
34. Louis DN: A molecular genetic model of astrocytoma histopathology. Brain Pathol 1997, 7(2): 755-764.
35. Saleh M, Wiegmans A, Malone Q, Stylli SS, Kaye AH: Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors. Journal of the National Cancer Institute 1999, 91(5): 438-445.
36. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP: Inhibition of angiogenesis by interleukin 4. J Exp Med 1998, 188(6): 1039-1046.
37. Linos E, Raine T, Alonso A, Michaud D: Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007, 99(20): 1544-1550.
38. Yang HJ: Association between the interleukin-4 gene C-589T and C+33T polymorphisms and asthma risk: a meta-analysis. Arch Med Res 2013, 44(2): 127-135.
39. Amirian ES, Marquez-Do D, Bondy ML, Scheurer ME: Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. Cancer Epidemiol 2013, 37(6): 908-912.
40. Schwartzbaum JA, Huang K, Lawler S, Ding B, Yu J, Chiocca EA: Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. Neuro Oncol 2010, 12(4): 320-327.
41. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H, Debinski W, Henriksson R, Feychting M: Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 2005, 65(14): 6459-6465.
42. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR et al: Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006, 66(8): 4531-4541.